MiR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2

Cell Death and Disease

Volumn 6, Issue 5, 2015, Pages

  An, Y ^a,b,c   Zhang, Z ^a,c   Shang, Y ^a,c   Jiang, X ^a,c   Dong, J ^a   Yu, P ^a   Nie, Y ^a   Zhao, Q ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b JINAN MILITARY GENERAL HOSPITAL   (China)

^c NINGBO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY RELATED GENE 12; HIGH MOBILITY GROUP B2 PROTEIN; MICRORNA; MICRORNA 23B 3P; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ATG12 PROTEIN, HUMAN; AUTOPHAGY RELATED PROTEIN 12; FLUOROURACIL; MIRN23 MICRORNA, HUMAN; SUMO PROTEIN; VINCRISTINE;

ARTICLE; AUTOPHAGY; CANCER CELL; CANCER RESISTANCE; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; GAIN OF FUNCTION MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN TARGETING; REPORTER GENE; STOMACH CANCER; WESTERN BLOTTING; BIOSYNTHESIS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; RNA INTERFERENCE; STOMACH; STOMACH NEOPLASMS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN 12; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGB2 PROTEIN; HUMANS; MICRORNAS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; STOMACH; STOMACH NEOPLASMS; VINCRISTINE;

EID: 84957310875     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.123     Document Type: Article

References (50)

1. Moore MA, Manan AA, Chow KY, Cornain SF, Devi CR, Triningsih FX et al. Cancer epidemiology and control in peninsular and island South-East Asia - past, present and future. Asian Pasc J Cancer Prev 2010; 11: 81-98.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Burris HA 3rd. Overcoming acquired resistance to anticancer therapy: focus on the PI3K/ AKT/mTOR pathway. Cancer Chemother Pharmacol 2013; 71: 829-842.
4. Fan D, Zhang X, Chen X, Mou Z, Hu J, Zhou S et al. Bird's-eye view on gastric cancer research of the past 25 years. J Gastroenterol Hepatol 2005; 20: 360-365.
5. Rebucci M, Michiels C. Molecular aspects of cancer cell resistance to chemotherapy. Biochem Pharmacol 2013; 85: 1219-1226.
6. Baguley BC.Multiple drug resistance mechanisms in cancer. Mol Biotechnol 2010; 46: 308-316.
7. Butler EB, Zhao Y, Munoz-Pinedo C, Lu J, Tan M. Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance. Cancer Res 2013; 73: 2709-2717.
8. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002; 108: 153-164.
9. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
10. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 2005; 353: 1768-1771.
11. Zhu Y, Yu F, Jiao Y, Feng J, Tang W, Yao H et al. Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5. Clin Cancer Res 2011; 17: 7105-7115.
12. Sun L, Yao Y, Liu B, Lin Z, Lin L, Yang M et al. MiR-200b and miR-15b regulate chemotherapyinduced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene 2012; 31: 432-445.
13. Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J et al. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Cancer Chemother Pharmacol 2012; 69: 723-731.
14. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008; 123: 372-379.
15. Shang Y, Zhang Z, Liu Z, Feng B, Ren G, Li K et al. miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1. Oncogene 2014; 33: 3267-3276.
16. Zhang H, Hao Y, Yang J, Zhou Y, Li J, Yin S et al.Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. Nat Commun 2011; 2: 554.
17. Zaman MS, Thamminana S, Shahryari V, Chiyomaru T, Deng G, Saini S et al. Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLoS One 2012; 7: e50203.
18. Li B, Sun M, Gao F, Liu W, Yang Y, Liu H et al. Up-regulated expression of miR-23a/b targeted the pro-apoptotic Fas in radiation-induced thymic lymphoma. Cell Physiol Biochem 2013; 32: 1729-1740.
19. Wang P, Zhang J, Zhang L, Zhu Z, Fan J, Chen L et al. MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cells. Gastroenterology 2013; 145: 1133-1143 e1112.
20. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81: 1-5.
21. Garofalo M, Croce CM. MicroRNAs as therapeutic targets in chemo-resistance. Drug Resist Updat 2013; 16: 47-59.
22. Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O et al. Molecular mechanisms of cisplatin resistance. Oncogene 2012; 31: 1869-1883.
23. Ma K, He Y, Zhang H, Fei Q, Niu D, Wang D et al. DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression. J Biol Chem 2012; 287: 5639-5649.
24. Wang Z, Wang N, Liu P, Chen Q, Situ H, Xie T et al. MicroRNA-25 regulates chemoresistance- associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin. Oncotarget 2014; 5: 7013-7026.
25. Cai J, Yang C, Yang Q, Ding H, Jia J, Guo J et al. Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin. Oncogenesis 2013; 2: e75.
26. Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M et al. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 2007; 67: 11111-11116.
27. Ishteiwy RA, Ward TM, Dykxhoorn DM, Burnstein KL. The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells. PLoS One 2012; 7: e52106.
28. Jin L, Wessely O, Marcusson EG, Ivan C, Calin GA, Alahari SK. Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-alpha in breast cancer. Cancer Res 2013; 73: 2884-2896.
29. Pellegrino L, Stebbing J, Braga VM, Frampton AE, Jacob J, Buluwela L et al. miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts. Nucleic Acids Res 2013; 41: 5400-5412.
30. Metlagel Z, Otomo C, Takaesu G, Otomo T. Structural basis of ATG3 recognition by the autophagic ubiquitin-like protein ATG12. Proc Natl Acad Sci USA 2013; 110: 18844-18849.
31. Otomo C, Metlagel Z, Takaesu G, Otomo T. Structure of the human ATG12 ~ ATG5 conjugate required for LC3 lipidation in autophagy. Nat Struct Mol Biol 2013; 20: 59-66.
32. Cufi S, Vazquez-Martin A, Oliveras-Ferraros C, Corominas-Faja B, Urruticoechea A, Martin- Castillo B et al. Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment. Oncotarget 2012; 3: 1600-1614.
33. Bianchi ME, Agresti A. HMG proteins: dynamic players in gene regulation and differentiation. Curr Opin Genet Dev 2005; 15: 496-506.
34. He Q, Liang CH, Lippard SJ. Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin. Proc Natl Acad Sci USA 2000; 97: 5768-5772.
35. Balasubramani M, Day BW, Schoen RE, Getzenberg RH. Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer. Cancer Res 2006; 66: 763-769.
36. Livesey KM, Kang R, Vernon P, Buchser W, Loughran P, Watkins SC et al. p53/HMGB1 complexes regulate autophagy and apoptosis. Cancer Res 2012; 72(8): 1996-2005.
37. Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu Y et al. HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia 2011; 25: 23-31.
38. Wu ZB, Cai L, Lin SJ, Xiong ZK, Lu JL, Mao Y et al. High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance. Neuro Oncol 2013; 15: 1264-1275.
39. Kwon JH, Kim J, Park JY, Hong SM, Park CW, Hong SJ et al. Overexpression of highmobility group box 2 is associated with tumor aggressiveness and prognosis of hepatocellular carcinoma. Clin Cancer Res 2010; 16: 5511-5521.
40. Rosenfeldt MT, Ryan KM. The multiple roles of autophagy in cancer. Carcinogenesis 2011; 3: 955-963.
41. Frankel LB, Lund AH. MicroRNA regulation of autophagy. Carcinogenesis 2012; 33: 2018-2025.
42. Wan G, Xie W, Liu Z, XuW, Lao Y, Huang N et al. Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway. Autophagy 2014; 10: 70-79.
43. Xu L, Beckebaum S, Iacob S, Wu G, Kaiser GM, Radtke A et al. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. J Hepatol 2014; 60: 590-598.
44. Chang Z, Huo L, Li K, Wu Y, Hu Z. Blocked autophagy by miR-101 enhances osteosarcoma cell chemosensitivity in vitro. Sci World J 2014; 2014: 794756.
45. Chiyomaru T, Seki N, Inoguchi S, Ishihara T, Mataki H, Matsushita R et al. Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/ 27b cluster in bladder cancer. Int J Oncol 2015; 46: 487-496.
46. Geng J, Luo H, Pu Y, Zhou Z, Wu X, Xu W et al. Methylation mediated silencing of miR-23b expression and its role in glioma stem cells. Neurosci Lett 2012; 528: 185-189.
47. Majid S, Dar AA, Saini S, Arora S, Shahryari V, Zaman MS et al. miR-23b represses protooncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer Res 2012; 72: 6435-6446.
48. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458: 762-765.
49. An Y, Zhou Y, Ren G, Tian Q, Lu Y, Li H et al. Elevated expression of MGb2-Ag/TRAK1 is correlated with poor prognosis in patients with colorectal cancer. Int J Colorectal Dis 2011; 26: 1397-1404.
50. Wu Q, Yang Z, An Y, Hu H, Yin J, Zhang P et al. MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1. Cell Death Dis 2014; 5: e1144.